Related references
Note: Only part of the references are listed.Myeloid -Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Fang Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Circulating Wnt inhibitory factor 1 levels are associated with development of cardiovascular disease
Claudia Ress et al.
ATHEROSCLEROSIS (2018)
Bone Loss After Romosozumab/Denosumab: Effects of Bisphosphonates
Anne M. Horne et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis
Ian Ackers et al.
CARDIOVASCULAR PATHOLOGY (2018)
Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidates
Hanne Skou Jorgensen et al.
CLINICAL NEPHROLOGY (2018)
Elevated levels of serum sclerostin are linked to adverse cardiovascular outcomes in peritoneal dialysis patients
Li Gong et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)
A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
E. Michael Lewiecki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Coronary arterial calcification: A review of mechanisms, promoters and imaging
Jordan Andrews et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2018)
Endothelial cell CD36 optimizes tissue fatty acid uptake
Ni-Huiping Son et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease
Cong Zeng et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis
Smriti Murali Krishna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Wnt signaling and cellular metabolism in osteoblasts
Courtney M. Karner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity
Nicole K. H. Yiew et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The Lrp4 R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans
Eveline Boudin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Osteoporosis in Crisis: It's Time to Focus on Fracture
Neil Binkley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Bente L. Langdahl et al.
LANCET (2017)
Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania
Agostino Gaudio et al.
MOLECULAR MEDICINE REPORTS (2017)
Romosozumab - on track or derailed?
Sundeep Khosla
NATURE REVIEWS ENDOCRINOLOGY (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis
Justin E. Lengfeld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Mitigation of sepsis-induced inflammatory responses and organ injury through targeting Wnt/β- catenin signaling
Archna Sharma et al.
SCIENTIFIC REPORTS (2017)
Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies
Carla Caffarelli et al.
CLINICAL INTERVENTIONS IN AGING (2017)
Wnt signaling in cardiovascular disease: opportunities and challenges
Austin Gay et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
Endothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis
Khiem A. Tran et al.
CIRCULATION (2016)
Bisphosphonates for cardiovascular risk reduction: A systematic review and meta-analysis
Guido Kranenburg et al.
ATHEROSCLEROSIS (2016)
Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria
Julio Gallego-Delgado et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells
Velidi H. Rao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Association of circulating sclerostin with vascular calcification in Afro-Caribbean men
Allison L. Kuipers et al.
ATHEROSCLEROSIS (2015)
Wnt signaling in atherosclerosis
W. Matthijs Blankesteijn et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Effects of oral administration of tripeptides derived from type I collagen (collagen tripeptide) on atherosclerosis development in hypercholesterolemic rabbits
Lihua Tang et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2015)
LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice
Maria Borrell-Pages et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients
P. Evenepoel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Alendronate prevents angiotensin II-induced collagen I production through geranylgeranylation-dependent RhoA/Rho kinase activation in cardiac fibroblasts
Yang Ye et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Impaired LRP6-TCF7L2 Activity Enhances Smooth Muscle Cell Plasticity and Causes Coronary Artery Disease
Roshni Srivastava et al.
CELL REPORTS (2015)
Endothelial Barrier and Its Abnormalities in Cardiovascular Disease
Dimitry A. Chistiakov et al.
FRONTIERS IN PHYSIOLOGY (2015)
Bisphosphonates: therapeutics potential and recent advances in drug delivery
Mohammad Fazil et al.
DRUG DELIVERY (2015)
Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
Dae Hyun Kim et al.
PLOS ONE (2015)
Wnt Signaling in Cardiac Disease
Kevin C. M. Hermansand et al.
COMPREHENSIVE PHYSIOLOGY (2015)
Canonical Wnt Signaling Induces Vascular Endothelial Dysfunction via p66Shc-Regulated Reactive Oxygen Species
Ajit Vikram et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women
S. Gonnelli et al.
BONE (2014)
Wnt5a, TLR2 and TLR4 are elevated in advanced human atherosclerotic lesions
Ramiro Malgor et al.
INFLAMMATION RESEARCH (2014)
Insulin-like Growth Factor-1 Increases Synthesis of Collagen Type I via Induction of the mRNA-binding Protein LARP6 Expression and Binding to the 5′ Stem-loop of COL1a1 and COL1a2 mRNA
Christopher D. Blackstock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Myocardial Infarction Risk Among Patients With Fractures Receiving Bisphosphonates
Cory B. Pittman et al.
MAYO CLINIC PROCEEDINGS (2014)
The Wnt/beta-Catenin Signaling Pathway Controls the Inflammatory Response in Infections Caused by Pathogenic Bacteria
Octavio Silva-Garcia et al.
MEDIATORS OF INFLAMMATION (2014)
Epigenome-Guided Analysis of the Transcriptome of Plaque Macrophages during Atherosclerosis Regression Reveals Activation of the Wnt Signaling Pathway
Stephen A. Ramsey et al.
PLOS GENETICS (2014)
The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women
Geeta Hampson et al.
BONE (2013)
LRP6 Enhances Glucose Metabolism by Promoting TCF7L2-Dependent Insulin Receptor Expression and IGF Receptor Stabilization in Humans
Rajvir Singh et al.
CELL METABOLISM (2013)
Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
Sonia Morales-Santana et al.
DIABETES CARE (2013)
Sclerostin: Another Vascular Calcification Inhibitor?
Kathleen J. Claes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
WNT signaling in bone homeostasis and disease: from human mutations to treatments
Roland Baron et al.
NATURE MEDICINE (2013)
Dickkopf-1 as a Novel Predictor Is Associated with Risk Stratification by GRACE Risk Scores for Predictive Value in Patients with Acute Coronary Syndrome: A Retrospective Research
Lin Wang et al.
PLOS ONE (2013)
The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases
Eveline Boudin et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?
Sabrina Ehnert et al.
BMC MEDICINE (2012)
Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure
Wenzhong Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Osteoporosis-a risk factor for cardiovascular disease?
Christos E. Lampropoulos et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Suppression of GSK3β by ERK mediates lipopolysaccharide induced cell migration in macrophage through β-catenin signaling
Kai Gong et al.
PROTEIN & CELL (2012)
The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans
Alexandre Marchand et al.
AGING CELL (2011)
Circulating Dickkopf-1 in acute ischemic stroke and clinically stable cerebrovascular disease
Thomas Seifert-Held et al.
ATHEROSCLEROSIS (2011)
Wnt4/β-Catenin Signaling Induces VSMC Proliferation and Is Associated With Intimal Thickening
Aikaterini Tsaousi et al.
CIRCULATION RESEARCH (2011)
Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages
Maria Borrell-Pages et al.
EUROPEAN HEART JOURNAL (2011)
Carotid artery atherosclerosis in hypertensive patients with a functional LDL receptor-related protein 6 gene variant
R. Sarzani et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Clodronate Liposomes Improve Metabolic Profile and Reduce Visceral Adipose Macrophage Content in Diet-Induced Obese Mice
Bin Feng et al.
PLOS ONE (2011)
Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation
Ali R. Keramati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia
Anne Saarinen et al.
CLINICAL ENDOCRINOLOGY (2010)
Levels of DKK1 in patients with acute myocardial infarction and response to atorvastatin
Jose Luis Perez Castrillon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Wnt5a Induces Endothelial Inflammation via β-Catenin-Independent Signaling
Jihun Kim et al.
JOURNAL OF IMMUNOLOGY (2010)
Bisphosphonates for Osteoporosis
Murray J. Favus
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dickkopf-1 Enhances Inflammatory Interaction Between Platelets and Endothelial Cells and Shows Increased Expression in Atherosclerosis
Thor Ueland et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The effect of alendronate sodium on carotid artery intima-media thickness and lipid profile in women with postmenopausal osteoporosis
Murat Celiloglu et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
The effects of zoledronic acid on serum lipids in multiple myeloma patients
Alessandro Gozzetti et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Mechanisms of anabolic therapies for osteoporosis
Ernesto Canalis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
LRP6 mutation in a family with early coronary disease and metabolic risk factors
Arya Mani et al.
SCIENCE (2007)
Activation of the canonical Wnt/β-catenin pathway enhances monocyte adhesion to endothelial cells
Dong Kun Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Wnt signaling regulates transendothelial migration of monocytes
Lara Tickenbrock et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice
M Shimshi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo
J Ezan et al.
CARDIOVASCULAR RESEARCH (2004)
Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis
C Kokubu et al.
DEVELOPMENT (2004)
Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E
K Magoori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion
T Fujino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol
S Adami et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Share Paper
